SCHEMBL12848842

SCHEMBL12848842

Cn1nnc(N2CCC3=C(C2)c2ncc(NC(=O)C4=CCCCC4)nc2CCC3)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12848743 0.82 — —
SCHEMBL12848903 0.81 TRPV1 (0.39) —
SCHEMBL12848849 0.81 HTR1F (0.40) —
SCHEMBL12848737 0.65 ALOX15 (0.31) —
SCHEMBL12848456 0.63 — —
SCHEMBL12848559 0.62 TP53 (0.37) —
SCHEMBL4999489 0.62 HDAC4 (0.35) —
SCHEMBL5019623 0.61 PTPN11 (0.34) —
SCHEMBL3825366 0.60 IL2 (0.44) —
SCHEMBL3826508 0.60 KMT2A (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110052643-A1 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2011-03-03 — — US disclosed
WO-2009089305-A1 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2009-07-16 — — WO disclosed
Send feedback